MCCANN JOE A. 4
4 · POINT Biopharma Global Inc. · Filed Jun 30, 2021
Insider Transaction Report
Form 4
MCCANN JOE A.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-06-30+3,614,153→ 3,614,153 total
Footnotes (1)
- [F1]On June 30, 2021, POINT BIOPHARMA GLOBAL INC. (f/k/a Therapeutics Acquisition Corp., the "Issuer") consummated a business combination (the "Business Combination") pursuant to which RACA, Bodhi Merger Sub, Inc., a wholly-owned subsidiary of the Issuer merged with and into POINT Biopharma Inc., ("Old POINT"). At the effective time of the Business Combination, each share of Old POINT outstanding as of immediately prior to the effective time was exchanged for shares of Common Stock of the Issuer based on an implied Old POINT vested equity value of $585,000,000. As a result, the Reporting Person received the reported shares of the Issuer's Common Stock in consideration for the equity securities of Old POINT held by the Reporting Person prior to the Business Combination.